Fischer Medical Ventures appoints three advisors for imaging and AI diagnostics
The appointments bring expertise in molecular imaging, biochip technologies and neurosurgery to the group, whose Indian operations include an MRI manufacturing facility in Visakhapatnam.
In a statement announcing the appointments, the company said their expertise would support its work across diagnostics, preventive care, wellness and healthcare innovation.
VISAKHAPATNAM: Fischer Medical Ventures has appointed Zhe Lin, Parasuraman Padmanabhan and Iype Cherian as senior advisors to strengthen its capabilities in medical technology, diagnostics, imaging and artificial intelligence.
In a statement announcing the appointments, the company said their expertise would support its work across diagnostics, preventive care, wellness and healthcare innovation.
India is the group’s largest operating base, with a manufacturing facility at the Andhra Pradesh MedTech Zone in Visakhapatnam. Its subsidiary, Time Medical International Ventures, manufactures MRI systems in India. The group also has businesses in preventive and digital health and life sciences.
Padmanabhan is a molecular imaging and nanomedicine researcher with more than 30 years of experience across India, the US, Singapore and Hungary. He is a research professor at Semmelweis University’s Faculty of Medicine in Budapest.
His work covers neuroimaging, molecular imaging, imaging probes, drug discovery and regenerative biology. According to the company, he has published approximately 170 peer-reviewed papers and 20 book chapters and became a Fellow of the Royal Society of Chemistry in 2023.
Lin specialises in biochip technologies, mechanobiology and AI-enabled medical diagnostics. An ETH Zurich doctorate holder, he is CEO and co-founder of Cell4D and co-founder and scientific advisor to CVDetect. His work includes single-cell screening, precision oncology and thrombosis detection.
Cherian is a neurosurgeon, inventor and educator who holds neuroscience leadership positions at Parul Institute of Medical Sciences & Research in Vadodara and KIMS in Karad. His work includes cisternostomy, microsurgical techniques, exoscope-based surgery and AI-enhanced visualisation.
Executive chairman and managing director Ravindran Govindan said the advisors’ experience and international perspectives would guide the group’s development of products integrating diagnostics, preventive care and wellness.
